ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $361,155 | +1705.8% | 119,193 | +1011.3% | 0.00% | – |
| Q3 2022 | $20,000 | -81.8% | 10,726 | -73.7% | 0.00% | -100.0% |
| Q2 2022 | $110,000 | -81.1% | 40,747 | -79.2% | 0.00% | -80.0% |
| Q1 2022 | $582,000 | -43.2% | 195,464 | -25.8% | 0.01% | -50.0% |
| Q4 2021 | $1,025,000 | +1667.2% | 263,588 | +1838.1% | 0.01% | +900.0% |
| Q3 2021 | $58,000 | -69.9% | 13,600 | -78.6% | 0.00% | -50.0% |
| Q2 2021 | $193,000 | -68.8% | 63,700 | -65.7% | 0.00% | -75.0% |
| Q1 2021 | $618,000 | +241.4% | 185,515 | +264.5% | 0.01% | +300.0% |
| Q4 2020 | $181,000 | +687.0% | 50,899 | +305.2% | 0.00% | – |
| Q2 2020 | $23,000 | +1050.0% | 12,562 | +1303.6% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 895 | +198.3% | 0.00% | – |
| Q3 2017 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |